Different prognosis in cutaneous early-onset and late-onset Merkel cell carcinoma: a population-based retrospective study
- PMID: 38863308
- DOI: 10.1111/ijd.17297
Different prognosis in cutaneous early-onset and late-onset Merkel cell carcinoma: a population-based retrospective study
Abstract
Background: Merkel cell carcinoma (MCC) is a rare and highly aggressive form of skin cancer. However, there is limited research on the clinicopathological features of early-onset MCC (EOMCC) and the differences between EOMCC and late-onset MCC (LOMCC). Our objective was to evaluate the clinicopathological features and cancer-specific survival (CSS) of EOMCC.
Methods: Our cohort study analyzed data from the Surveillance, Epidemiology, and End Results (SEER) database from January 1, 2018, to December 31, 2020. Data from 1941 patients who were diagnosed with primary cutaneous MCC were included. We then divided the patients with MCC into two groups: those with EOMCC (526 patients) and those with LOMCC (1415 patients). CSS is used as the primary outcome.
Results: The EOMCC group exhibited trends toward advanced tumor progression, an expanded surgical scope, increased lymph node retrieval, intensified radiotherapy, greater utilization of systemic therapy, and a better prognosis. Multivariate analysis revealed that LOMCC (HR 3.305 [2.002-5.456], P < 0.001), advanced T stage (HR 1.430 [1.139-1.797], P = 0.002), advanced N stage (HR 1.522 [1.221-1.897], P < 0.001), M1 stage (HR 2.587 [1.480-4.521], P < 0.001), and radiation (HR 0.586 [0.410-0.837], P = 0.003) were significantly associated with CSS. Among these factors, EOMCC/LOMCC was most strongly associated with CSS, indicating that LOMCC is an independent risk factor for CSS. Interestingly, we found that regional EOMCC and localized or in situ LOMCC had almost completely overlapping survival curves (Plog-rank = 0.620). Additionally, we observed that the TNM staging + age model was a more accurate predictor of CSS among MCC patients than using TNM staging alone.
Conclusions: We found that EOMCC has distinct clinicopathological features compared to LOMCC. EOMCC is associated with better CSS. The combination of TNM staging and age was more accurate for predicting patient outcomes than TNM staging alone.
Keywords: Merkel cell carcinoma; clinical dermatology; clinicopathological feature; early‐onset; prognosis; skin cancer; staging system.
© 2024 the International Society of Dermatology.
Similar articles
-
Evaluation of Lymph Node Ratio Association With Long-term Patient Survival After Surgery for Node-Positive Merkel Cell Carcinoma.JAMA Dermatol. 2019 Jul 1;155(7):803-811. doi: 10.1001/jamadermatol.2019.0267. JAMA Dermatol. 2019. PMID: 30825411 Free PMC article.
-
Quantitative metastatic lymph node burden and survival in Merkel cell carcinoma.J Am Acad Dermatol. 2021 Feb;84(2):312-320. doi: 10.1016/j.jaad.2019.12.072. Epub 2020 Jan 16. J Am Acad Dermatol. 2021. PMID: 31954753
-
Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data.Laryngoscope. 2012 Jun;122(6):1283-90. doi: 10.1002/lary.23222. Epub 2012 Apr 20. Laryngoscope. 2012. PMID: 22522673
-
Merkel cell carcinoma in East Yorkshire: A case series and literature review of current management.J Plast Reconstr Aesthet Surg. 2015 May;68(5):667-72. doi: 10.1016/j.bjps.2014.12.021. Epub 2015 Jan 6. J Plast Reconstr Aesthet Surg. 2015. PMID: 25595515 Review.
-
Merkel cell carcinoma: clinicopathological aspects of an unusual neoplasm.J BUON. 2007 Apr-Jun;12(2):173-9. J BUON. 2007. PMID: 17600868 Review.
References
-
- Becker JC, Stang A, DeCaprio JA, Cerroni L, Lebbé C, Veness M, et al. Merkel cell carcinoma. Nat Rev Dis Primers. 2017;3:17077.
-
- Patel P, Hussain K. Merkel cell carcinoma. Clin Exp Dermatol. 2021;46(5):814–819.
-
- McEvoy AM, Lachance K, Hippe DS, Cahill K, Moshiri Y, Lewis CW, et al. Recurrence and mortality risk of Merkel cell carcinoma by cancer stage and time from diagnosis. JAMA Dermatol. 2022;158(4):382–389.
-
- Jacobs D, Huang H, Olino K, Weiss S, Kluger H, Judson BL, et al. Assessment of age, period, and birth cohort effects and trends in Merkel Cell carcinoma incidence in the United States. JAMA Dermatol. 2021;157(1):59–65.
-
- Cornejo C, Miller CJ. Merkel cell carcinoma: Updates on staging and management. Dermatol Clin. 2019;37(3):269–277.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical